Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Tumour Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07487519
What this trial is testing

Phase II Study of HLX43 Monotherapy or Combined With Immune Checkpoint Inhibitors in Patients With Locally Advanced, Recurrent, or Metastatic Triple-negative Breast Cancer.

Who this might be right for
Breast Cancer (Triple Negative Breast Cancer (TNBC))
Shanghai Henlius Biotech 180
Early research (Phase 1)Study completedNCT03502330
What this trial is testing

APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma

Who this might be right for
Advanced MelanomaNon-small Cell Lung CancerRenal Cell Carcinoma
Yale University 42
Large-scale testing (Phase 3)Study completedNCT00314977
What this trial is testing

Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.

Who this might be right for
Breast Cancer
Radboud University Medical Center 200
Not applicableNot Yet RecruitingNCT07410767
What this trial is testing

Advanced Endoscopic Resections for Rectal Neoplasms

Who this might be right for
Rectal CancerRectal AdenocarcinomaRectal Adenoma+2 more
Jagiellonian University 300
Not applicableStudy completedNCT01304667
What this trial is testing

Chemo- and Radiotherapy in Epithelial Vulvar Cancer

Who this might be right for
Radio/Chemotherapy in Node Positive Advanced Vulvar Cancer
AGO Study Group 1,618
Testing effectiveness (Phase 2)Study completedNCT00769483
What this trial is testing

MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Adenocarcinoma
M.D. Anderson Cancer Center 81
Testing effectiveness (Phase 2)Ended earlyNCT02473094
What this trial is testing

Neoadjuvant Metformin in Association to Chemoradiotherapy for Locally Advanced Rectal Cancer

Who this might be right for
Rectal NeoplasmsAdenocarcinomaCarcinoma
University of Campinas, Brazil 3
Testing effectiveness (Phase 2)Study completedNCT00008151
What this trial is testing

Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00942331
What this trial is testing

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

Who this might be right for
Advanced Urothelial CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Prostate Carcinoma+10 more
National Cancer Institute (NCI) 506
Not applicableWithdrawnNCT01325753
What this trial is testing

Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body

Who this might be right for
Advanced Malignant MesotheliomaExtensive Stage Small Cell Lung CancerLung Metastases+4 more
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Looking for participantsNCT03964753
What this trial is testing

Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Hebei Medical University Fourth Hospital 202
Testing effectiveness (Phase 2)UnknownNCT02705612
What this trial is testing

Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer

Who this might be right for
Cervical Cancer
Air Force Military Medical University, China 60
Testing effectiveness (Phase 2)Ended earlyNCT02269670
What this trial is testing

Phase II Study of Everolimus Beyond Progression

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerProgesterone Receptor-positive Breast Cancer+5 more
Emory University 3
Early research (Phase 1)Study completedNCT00882973
What this trial is testing

Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Samyang Biopharmaceuticals Corporation 18
Testing effectiveness (Phase 2)Study completedNCT00050141
What this trial is testing

Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer

Who this might be right for
Breast Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 121
Not applicableUnknownNCT04942756
What this trial is testing

GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients.

Who this might be right for
Palliative CareDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1+6 more
Antea Foundation 118
Early research (Phase 1)Study completedNCT02655822
What this trial is testing

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

Who this might be right for
Renal Cell CancerMetastatic Castration Resistant Prostate Cancer
Corvus Pharmaceuticals, Inc. 502
Testing effectiveness (Phase 2)Looking for participantsNCT05983237
What this trial is testing

Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma

Who this might be right for
Melanoma
Jun Guo 50
Early research (Phase 1)Study completedNCT04773951
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors

Who this might be right for
MelanomaRenal CarcinomaUrothelial Carcinoma
Shanghai Junshi Bioscience Co., Ltd. 47
Early research (Phase 1)Study completedNCT05327231
What this trial is testing

IN10018 Monotherapy or in Combination With Docetaxel in Gastric or GEJ Adenocarcinoma

Who this might be right for
Gastric Cancer
InxMed (Shanghai) Co., Ltd. 33
Next Page